key: cord-0823690-bgrb8y4j
authors: Galanis, P.; Kaitelidou, D.; Prezerakos, P.; Kotsiopoulos, I.; Siskou, O.; Konstantakopoulou, O.; Hadjichristodoulou, C.; Tsiodras, S.
title: Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece
date: 2021-07-31
journal: Public Health
DOI: 10.1016/j.puhe.2021.07.029
sha: 886f38cbbf2b9888773c7d4fa586b7b49898731a
doc_id: 823690
cord_uid: bgrb8y4j

Objectives To estimate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity among healthcare workers (HCWs) in Greece and to identify high risk groups in healthcare facilities. Study design Nationwide cross-sectional study. Methods Data were collected from 1 June to 9 July 2020. HCWs in the Greek National Health System were offered a free SARS-CoV-2 IgG antibody test, regardless of symptoms. Results Overall, 379 of 57,418 HCWs (0.66%, 95% confidence interval [CI] 0.59-0.73) were positive for SARS-CoV-2 antibodies. The adjusted overall seroprevalence was 0.43% (95% CI 0.35-0.51). We found that HCWs in non-reference hospitals for COVID-19 (odds ratio [OR] 1.81, 95% CI 1.23-2.64; P = 0.002) and reference hospitals for COVID-19 (OR 1.66, 95% CI 1.06-2.58; P = 0.03) were more likely to be seropositive than HCWs in primary care centres. Regarding professions, nurses (OR 1.45, 95% CI 1.07-1.98; P = 0.02), physicians (OR 1.43, 95% CI 1.06-1.93; P = 0.02), and administrative, cleaning and security staff (OR 1.50, 95% CI 1.09-2.06; P = 0.01) had a statistically higher chance of having a positive serology than laboratory employees. Conclusions The adjusted overall seroprevalence found in this study indicates a very low prevalence of SARS-CoV-2 among HCWs in Greece. This result is in line with the low incidence of COVID-19 during the first wave of the pandemic and is a direct benefit from the early implementation of lockdown.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which originated from China in late 2019, was declared a pandemic by the World Health Organisation (WHO) on 11 March 2020 [1] . Greece underwent a nationwide lockdown during the first phase of the pandemic that was gradually lifted from May 2020. At the end of June 2020, a total of 3049 cases and 193 deaths were reported nationwide [2] .

Mortality from COVID-19 in Greece at that point was one of the lowest in the world, An increase in transmission of SARS-CoV-2 may lead to an uncontrolled expansion in COVID-19 cases, which can cause a major challenge for national health systems.

Countries around the globe have responded in different ways to the pandemic. During the initial stages of the pandemic, Greece developed an efficient crisis management system taking into account the health system characteristics, the available healthcare resources and surge capacity to face the pandemic. This led to the early implementation of a nationwide lockdown in March 2020. This swift response was accompanied by an effort to develop and put in place a number of policies and reforms to meet the population health needs as a result of the pandemic. The strategies implemented were based on an evidence-informed, systematic and comprehensive strategic approach [4] .

Healthcare workers (HCWs) represent a high-risk group for SARS-CoV-2 infection due to their close and frequent contact with COVID-19 patients [5, 6] . Nosocomial specialised COVID-19 health centres, operating 24 hours/day, which are solely for the screening and management of mild COVID-19 cases [4] . Moreover, the role of primary healthcare in achieving sufficient COVID-19 vaccination coverage as quickly as possible is also essential [9] .

Fortunately, COVID-19 vaccination programmes in the HCW population commenced worldwide in January 2021 and have already shown a positive impact on COVID-19 incidence [10-12]. However, according to a meta-analysis, the intention of HCWs to receive COVID- 19 In addition to the great variability of COVID-19 vaccination acceptance among HCWs in different countries, it is also important to understand which HCWs are at greatest risk, thus determining priority HCW groups for vaccination and targeting information about vaccination programmes and protective measures. Therefore, the aim of the present study was to estimate the prevalence of SARS-CoV-2 seropositivity among HCWs in Greece, to identify high risk HCW groups in healthcare facilities and to find hotspots of the disease in the different regional units of the country. To the best of our knowledge, this is the first nationwide study in the world to estimate the prevalence of SARS-CoV-2 antibodies among HCWs.

J o u r n a l P r e -p r o o f

A nationwide cross-sectional HCW SARS-CoV-2 seroprevalence study was conducted from 1 June to 9 July 2020. A free SARS-CoV-2 IgG antibody test was offered to all HCWs working in the 110 hospitals and 377 primary healthcare centres throughout the country. The Greek government offered a free SARS-CoV-2 IgG antibody test in all HCWs anytime during the study. At the time of study, a total of 86,421 HCWs and administrative staff were informed about the aims and methods of our study. The test was performed on a voluntary and anonymous basis and was offered irrespective of past history of COVID-19. Blood sampling was organised and performed by the Departments of Clinical Laboratory and Biochemistry in the participating hospitals.

The presence of SARS-CoV-2 IgG antibodies was determined with the EUA-approved and CE-marked Abbott Architect™ SARS-CoV-2 IgG assay (Architect™) [17] [18] [19] .

The assay detects the presence of IgG antibodies against the SARS-CoV-2 nucleocapsid (N) protein. A chemiluminescent microparticle immunoassay (CLIA) was used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the ARCHITECT i System (ARCHITECT i2000SR analyzer) [20] . SARS-CoV-2 IgG antibodies in each sample were determined by comparing its chemiluminescent relative light unit (RLU) to the calibrator RLU (index S/C). The assay is highly sensitive and specific [17, 21, 22 ]. The samples were tested according to the manufacturer instructions.

The study was performed at the request of the Hellenic Prefectural Health authorities.

The Greek National Committee of Public Health against COVID-19 approved the study design (reference number; 44, 27-04-2020) and the Greek Ministry of Health institutional review board approved the use of the database (reference number; 894, 2020).

The crude prevalence of antibodies to SARS-CoV-2 (i.e. the proportion of individuals with a positive result) was the outcome. We calculated the crude prevalence as a J o u r n a l P r e -p r o o f fraction, dividing the number of individuals with a positive antibody test by the total number of individuals that were tested. In addition, the adjusted prevalence [23] was calculated according to the manufacturer's specification (sensitivity, 100%; specificity, 99.6%) and to the results of a study [22] conducted in a sample of the general population in Greece (sensitivity, 84%; specificity, 99.7%). Greece consists of 74 regional administrative units and we calculated crude and adjusted prevalence for these units.

We investigated associations between seropositivity for SARS-CoV-2 and sex, age, type of healthcare facility (i.e. hospital, reference hospital for COVID-19 or primary healthcare centre), job role (i.e. physician, nurse, administrative, cleaning, security or laboratory staff) and district by creating bivariate and multivariable logistic regression models. First, a bivariate logistic regression of each independent variable (i.e. sex, age, type of healthcare facility, job role and district) was carried out. Then, all independent variables were included in a multivariable logistic regression model with enter method.

We performed multivariate analysis to eliminate confounding. Odds ratios (ORs), 95% confidence intervals (CIs) and p-values (two-sided) for seropositivity were estimated.

Finally, we performed a post-hoc analysis regarding multiple level variables with seropositivity as the dependent variable to give a direct multiple-pairwise comparison.

We did not include districts in the post-hoc analysis since the number of categories was too many to inference reliable results. IBM SPSS was used for the analysis (IBM Corp. 

A total of 86,421 HCWs and administrative staff were invited to participate; 57,418 individuals participated, resulting in a 66.4% response rate. For participating individuals, 50,067 (87.2%) worked in hospitals and 7351 (12.8%) in primary healthcare centres (Table I ). In total, 9060 HCWs worked in a tertiary care hospital, designated as a reference COVID-19 centre according to the COVID-19 national pandemic response plan. The age distribution of participants is shown in the Table I. The 18-59-year-old age groups were equally distributed compared to the ≥60 years age group (n = 4511, 9%). The mean (standard deviation) age was 46.4 (10.1) years and the majority of participants were female (40, 866 HCWs, 73.5%). With regards to healthcare role, the majority of participating individuals were laboratory staff (n = J o u r n a l P r e -p r o o f 6 16,060, 32.1%), followed by physicians (n = 13,043, 25.7%) and nurses (n = 11,262, 22.2%) (Table I) .

Overall, 379 of 57,418 HCWs (0.66%, 95% CI 0.59-0.73) were positive for SARS-CoV-2 antibodies. The adjusted overall seroprevalence was 0.43% (95% CI 0.35-0.51).

According to bivariate logistic regression analysis, there was no significant association between age, gender and prevalence (Table II) . However, healthcare facility, job role and district were related to prevalence. These findings were confirmed by the multivariable adjusted logistic regression model and post-hoc analysis (Table II 

To the best of our knowledge, this is the first and largest nationwide study in the world to estimate the prevalence of SARS-CoV-2 antibodies among HCWs. The adjusted overall seroprevalence in this study was 0.43%, indicating a very low prevalence of SARS-CoV-2 among HCWs in Greece, which is consistent with the low burden of COVID-19 in the country during the first wave of the pandemic. This is an important direct benefit of the implementation of the early lockdown. In particular, case fatality rate of COVID-19 in Greece was 1.6% [24] and the mortality rate was 12.6 per 100,000 population on 20 November 2020 [3]. The 0.43% seroprevalence in a population of more than 50,000 HWCs and other hospital staff in Greece, is lower than previously reported results among 1495 HCWs in two hospitals in Greece (1.07%) during April-May 2020 [25] . The current study was performed during a period when there was no J o u r n a l P r e -p r o o f wide circulation of the virus in Greece and this could serve as a possible explanation for the very low seroprevalence. In accordance with our results, general Greek population data, as well as recent studies evaluating different populations, also showed low seroprevalence rates for SARS-CoV-2 infection. In particular, Bogogiannidou et al. [22] found an even lower seroprevalence (0.25% during April 2020) than our estimation using a non-random and convenience sample from the general population.

Moreover, preliminary results for June 2020 from the same study have shown an even lower seroprevalence (0.17%, personal communication). Two studies, one in London [26] and one in Stockholm, [27] confirm this finding, indicating that the HCW population is at increased risk of being exposed and acquiring SARS-CoV-2 infection.

In contrast, the seroprevalence among the personnel and students of the most highly populated university in Greece (National and Kapodistrian University of Athens) was higher (0.93% during June and July 2020) than our estimation [28] . This higher seroprevalence might be explained due to the fact that a significant proportion of University personnel are HCWs at COVID-19 reference hospitals, thus representing a high-risk group for SARS-CoV-2 exposure and infection, especially during the first months of the COVID-19 pandemic when knowledge about the virus and appropriate infection control was limited (similar to experiences in other countries) [29] . Also, our study population included HCWs from in primary health centres, where seropositivity was lower than HCWs in hospitals.

Worldwide, a wide range of seropositivity has been reported among HCWs. Two metaanalyses [30, 31] found a 7% and 8.7% seroprevalence among HCWs worldwide. In particular, seroprevalence among HCWs in Europe (8.5%) was reportedly lower than HCWs in North America (12.7%) but higher than those in Africa (8.2%) and Asia (4%) [31] . These variabilities, besides the phase of the epidemic, may be attributed to different use of personal protective equipment among HCWs in different countries, different infection prevention and control measures, and different responses of healthcare systems to the COVID-19 pandemic [32] [33] [34] [35] . For example, appropriate training protocols for HWCs results in very low SARS-CoV-2 infection rates, even in highly affected areas, such as Wuhan, China [36] .

According to our analysis, seropositivity was higher among HCWs in hospitals (both reference and non-reference hospitals for COVID-19) than primary care centres during the first wave of COVID-19 pandemic in Greece, a finding that has been observed in J o u r n a l P r e -p r o o f 8 other studies [25, [37] [38] [39] . This is indicative of erroneous use of personal protective equipment and has important implications for infection control policies, including training in hospitals at early phases of local epidemics or between phases. Such policies could decrease the risk of SARS-CoV-2 infection [37] [38] [39] . Strict infection control measures in COVID-19 units are especially important. Several studies [26, 27, 40] reported that the prevalence of SARS-CoV-2 antibodies was higher among HCWs working in COVID-19 units since HCWs in these settings have a higher exposure risk.

Also, patient-related work is an important factor associated with seropositivity among HCWs, even in non-COVID-19 units [26, 27, 40] . It is possible that HCWs in nonreference hospitals for COVID-19 feel safer and demonstrate lower compliance to prevention and control measures in general (e.g. poor hand hygiene and inappropriate use of personal protective equipment).

In our study, seropositivity was higher among nurses, while Plebani et al. [41] and Rudberg et al. [27] found that healthcare assistants were the occupational group with the highest seroprevalence. Nurses and healthcare assistants have a high exposure risk due to increased amounts of time with direct patient contact. Also, administrative, cleaning and security staff were more likely to be seropositive than HCWs in primary care centres. Administrative, cleaning and security workers have close contact with patients in healthcare facilities and it is likely that these workers do not apply the appropriate measures of hygiene (e.g. use mask, gloves) since they are not well trained, especially in case of the COVID-19 pandemic.

Regarding geographical distribution of SARS-CoV-2 antibodies in HCWs in Greece, seroprevalence was higher than the overall seroprevalence of 0.43% in 13 out of the 74 regional units, with the highest being in Kastoria (6.11%). Kastoria was one of the first hotspots for SARS-CoV-2 virus infection in the country, after introduction of the infection from visitors coming from the Northern Italy epidemic and working in the local fur industry. Also, seroprevalence was reasonably higher than the overall seroprevalence only in one district (Western Macedonia) and reasonably lower in the Greek islands.

Limitations of this study include the voluntary testing; thus, a selection bias is possible, especially with regard to female HCWs. Nevertheless, only a statistical trend was identified for male gender. It is well known that the virus is associated with more severe J o u r n a l P r e -p r o o f disease in males, thus one would expect a higher seroprevalence in men. In addition, we investigated only four potential factors as predictors for positive antibody test, while the cross-sectional nature of the study did not allow for causal inferences. Furthermore, we lacked information on history of infection or symptoms consistent with a SARS-CoV-2 infection or history of contact with a positive case within the household or elsewhere outside the hospital. Case ascertainment may not be a big issue in seroprevalence studies targeting HCWs, as this population has better access to, and lower clinical thresholds for, laboratory testing for virus presence. The proportion of asymptomatic individuals within the HCW population is largely unknown but is not expected to differ from rates reported from large community studies [42] . Repeated serology surveys in HCWs would greatly enhance knowledge on transmission dynamics in this vulnerable population, as well as the potential contribution of asymptomatic cases. The specific environment where HCWs work inside the hospital is another potential important factor that may contribute to an increased risk of infection (e.g. HCW working in the Emergency Room or in a designated COVID-19 reference centre or being involved in direct patient care). Information on consistent use of personal protective measures is another important parameter associated with seropositivity to the novel coronavirus [29] that was not systematically collected during this study.

In conclusion, the very low prevalence of SARS-CoV-2 antibodies in the present study likely reflects the timely implementation of social distancing measures during the first phase of the COVID-19 pandemic in Greece [43] . The swift adoption of a range of measures had a significant impact on the low prevalence of the disease among HCWs as well as the general population in Greece. The containment measures managed to 'flatten the curve' in a timely manner and therefore minimised exposure risk, severe illness rates and mortality rates for the entire population, including HCWs. Moreover, decision-makers should pay attention to high-risk HCWs who may be impacted by COVID-19 (e.g. HCWs in hospitals, nurses, physicians). Identification of high-risk HCWs is necessary to apply the appropriate measures, such as extra personal protective equipment, prioritisation for COVID-19 vaccination and appropriate training.

The authors would like to thank the healthcare workers and the laboratory workers who participated in the study.

The study was performed at the request of the Hellenic Prefectural Health authorities. Table IV . Prevalence of antibodies to SARS-CoV-2 among healthcare workers in Greece by regional unit. in Greece. Adjusted prevalences according to Bogogiannidou et al. [22] are shown.

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

European Centre for Disease Prevention and Control. COVID-19 situation updates for the EU/EEA and the UK. n.d

Health System Response Monitor in Greece

Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider

COVID-19 and Risks Posed to Personnel During Endotracheal Intubation

Harnessing the potential of the primary healthcare facilities in India to respond COVID-19 pandemic: A scoping evidence-based research synthesis

Empowering primary healthcare institutions against COVID-19 pandemic: A health system-based approach

Mass immunization and COVID-19: the need for continued primary health care

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

Comparative Clinical Evaluation of the Roche Elecsys and Abbott SARS-CoV-2 Serology assays for COVID-19

Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies

Estimating Prevalence Using an Imperfect Test

Our World in Data

Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19. Infectious Diseases (except HIV/AIDS)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust

SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers

Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network -13

COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes

Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and meta-analysis

China's practice to prevent and control COVID-19 in the context of large population movement

Comparisons between countries are essential for the control of COVID-19

The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study

What China's coronavirus response can teach the rest of the world

Preparedness of medical education in China: Lessons from the COVID-19 outbreak

Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China

SARS-CoV-2 seroconversion in health care workers

Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review

Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

SARS-CoV-2 serosurvey in health care workers of the Veneto Region

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Modelling the SARS-CoV-2 first epidemic wave in Greece: social contact patterns for impact assessment and an exit strategy from social distancing measures

Western Macedonia